Marsh

MMC · NYSE

$191.26+$2.76 (+1.46%)TodayMarket closed · Oct 20, 4:00 PM ET

Prev close $188.50

MMC analyst rating

HoldConsensus of 11 analysts over the last 12 months. 45% rate it a buy.

Strong buy0
Buy5
Hold5
Underperform1
Sell0

12-month price target · 23 analysts

Average $214.06 (+11.9% upside)

Low: $175.74
Now: $191.26
High: $270.90

Upgrades and downgrades

The latest rating actions, newest first

MMC analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Cantor Fitzgerald	Jan 14, 2026	Maintains	Overweight	$226.00 → $208.00	62%
Wells Fargo	Jan 13, 2026	Maintains	Equal-Weight	$212.00 → $199.00	60%
Barclays	Jan 8, 2026	Maintains	Overweight	$206.00 → $210.00	61%
Evercore ISI Group	Jan 7, 2026	Maintains	Outperform	$237.00 → $236.00	56%
JP Morgan	Jan 7, 2026	Maintains	Overweight	$242.00 → $226.00	57%
Keefe, Bruyette & Woods	Jan 6, 2026	Maintains	Market Perform	$191.00 → $205.00	68%
Mizuho	Dec 16, 2025	Initiates	Outperform	$212.00	58%
Citigroup	Dec 4, 2025	Maintains	Neutral	$211.00 → $201.00	59%
Barclays	Nov 20, 2025	Upgrade	Equal-Weight → Overweight	$221.00 → $206.00	61%
TD Cowen	Nov 3, 2025	Maintains	Hold	$213.00 → $200.00	54%

The case for and against

Updated May 30, 2025

Bull case

Marsh & McLennan Cos has demonstrated a consistent trend of improving margins for seventeen consecutive years, with further enhancement anticipated in 2025 and 2026, indicating strong operational efficiency. The Risk & Insurance Services segment has recently experienced robust organic growth, with expectations for continued strength in Marsh agency and Guy Carpenter, particularly in emerging international markets. Additionally, favorable macroeconomic conditions and the strategic McGriff acquisition are expected to enhance revenue generation and strengthen the company's position in the middle market, contributing positively to future performance.

Bear case

Marsh & McLennan Cos is facing a negative outlook primarily due to anticipated margin deterioration of 20 basis points, stemming from softer-than-expected revenue performance and increased investment spending. The company has revised its operating cash EPS estimates downward for 2025 and 2026, reflecting lower organic growth and margin expectations in both its Risk and Insurance Services and Consulting segments. Additionally, macroeconomic conditions are expected to soften globally, potentially impacting Marsh & McLennan's performance, further compounded by foreign exchange-related headwinds anticipated to affect first-quarter results.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.